Evidence map›Paper›PMID 24983942›Full record

ArticlePloS one2014

Miz-1 activates gene expression via a novel consensus DNA binding motif.

Bonnie L Barrilleaux, Dana Burow, Sarah H Lockwood, Abigail Yu, David J Segal, Paul S Knoepfler

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ubiquitination by HUWE1 in tumorigenesis and beyond.Journal of biomedical science · 2018
    Review
  7. Article
  8. Review
  9. Article
  10. Role of MIZ-1 inBiochemistry and biophysics reports · 2016
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bonnie L BarrilleauxDepartment of Cell Biology and Human Anatomy, University of California Davis School of Medicine, Davis, California, United States of America; Genome Center, University of California Davis, Davis, California, United States of America; Comprehensive Cancer Center, University of California Davis, Sacramento, California, United States of America; Institute of Pediatric Regenerative Medicine, Shriners Hospital For Children Northern California, Sacramento, California, United States of America.
Dana BurowDepartment of Cell Biology and Human Anatomy, University of California Davis School of Medicine, Davis, California, United States of America; Genome Center, University of California Davis, Davis, California, United States of America; Comprehensive Cancer Center, University of California Davis, Sacramento, California, United States of America; Institute of Pediatric Regenerative Medicine, Shriners Hospital For Children Northern California, Sacramento, California, United States of America.
Sarah H LockwoodGenome Center, University of California Davis, Davis, California, United States of America; Department of Biochemistry, University of California Davis, Davis, California, United States of America.
Abigail YuGenome Center, University of California Davis, Davis, California, United States of America; Department of Biochemistry, University of California Davis, Davis, California, United States of America.
David J SegalGenome Center, University of California Davis, Davis, California, United States of America; Department of Biochemistry, University of California Davis, Davis, California, United States of America.
Paul S KnoepflerDepartment of Cell Biology and Human Anatomy, University of California Davis School of Medicine, Davis, California, United States of America; Genome Center, University of California Davis, Davis, California, United States of America; Comprehensive Cancer Center, University of California Davis, Sacramento, California, United States of America; Institute of Pediatric Regenerative Medicine, Shriners Hospital For Children Northern California, Sacramento, California, United States of America.
University of California, Davis · US

Funding

Training Program in Oncogenic Signals and Chromosome BiologyT32CA108459 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HEYER, WOLF-DIETRICH · 2006 to 2020
$3.6M
Myc Regulation of Embryonic Stem Cell Self-Renewal and PluripotencyR01GM100782 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KNOEPFLER, PAUL S · 2011 to 2015
$1.4M
NextGen DNA Binding Proteins Based on TAL DomainsR01GM097073 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SEGAL, DAVID J · 2011 to 2014
$1.1M
NCI NIH HHS T32 CA108459NCI NIH HHS T32 CA108459-07NIGMS NIH HHS 1R01GM100782NIGMS NIH HHS R01 GM097073NIGMS NIH HHS R01 GM100782
6 · The paper itself

Abstract

The transcription factor Miz-1 can either activate or repress gene expression in concert with binding partners including the Myc oncoprotein. The genomic binding of Miz-1 includes both core promoters and more distal sites, but the preferred DNA binding motif of Miz-1 has been unclear. We used a high-throughput in vitro technique, Bind-n-Seq, to identify two Miz-1 consensus DNA binding motif sequences--ATCGGTAATC and ATCGAT (Mizm1 and Mizm2)--bound by full-length Miz-1 and its zinc finger domain, respectively. We validated these sequences directly as high affinity Miz-1 binding motifs. Competition assays using mutant probes indicated that the binding affinity of Miz-1 for Mizm1 and Mizm2 is highly sequence-specific. Miz-1 strongly activates gene expression through the motifs in a Myc-independent manner. MEME-ChIP analysis of Miz-1 ChIP-seq data in two different cell types reveals a long motif with a central core sequence highly similar to the Mizm1 motif identified by Bind-n-Seq, validating the in vivo relevance of the findings. Miz-1 ChIP-seq peaks containing the long motif are predominantly located outside of proximal promoter regions, in contrast to peaks without the motif, which are highly concentrated within 1.5 kb of the nearest transcription start site. Overall, our results indicate that Miz-1 may be directed in vivo to the novel motif sequences we have identified, where it can recruit its specific binding partners to control gene expression and ultimately regulate cell fate.

Indexed as

Arabidopsis ProteinsBinding SitesChromatin ImmunoprecipitationDNAElectrophoretic Mobility Shift AssayGene Expression RegulationGenes, ReporterHumansLuciferasesArabidopsis ProteinsDNALuciferasesmizu-kussei1 protein, Arabidopsis

Identifiers

PMID24983942
PMCPMC4077741
OpenAlexW2020965615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.